semaglutide and methylprednisolone Diabetes Drug Could Help Reduce Risk for Cardiovascular Events, Study Finds like peptide Injectable Weight Loss Medications in
Description
Clin Kidney J 16:797808

Traditional high-calorie snacking categories and center-store products are seeing reduced consumption, slowing growth for portfolios heavily indexed to these areas

Real Chemistry State Analysis State-by-State Medicaid Coverage of GLP-1 Weight Loss Medications (realchemistry.com, December 15, 2024, updated January 2, 2025) Detailed breakdown of which state Medicaid programs cover obesity GLP-1 drugs and spending data

Premature Mortality Multiple longitudinal studies have confirmed that higher levels of visceral fat are associated with increased all-cause mortality, even in individuals with normal body mass index (BMI)
